Stelex and VelQuest to Improve Productivity in Pharmaceutical Labs
Bensalem, PA and Hopkinton, MA, January 27, 2004 — Stelex, a firm providing enterprise-wide compliance solutions to the regulated industries and VelQuest, the developer of SmartLab™, the only automated lab compliance platform available in the market, announced today, a strategic alliance to provide End-to–End Solutions that improve productivity and compliance in pharmaceutical labs.
It is estimated that approximately 70% of laboratory resources are dedicated to meeting compliance standards. The implementation of an automated laboratory system ensures compliance, as well as improves productivity by greater than 50%, allowing scientists to focus more on science to fill product pipelines and increase value.
“Our strategic alliance with Stelex benefits all facets of the Pharmaceutical industry by providing a complete automated compliance solution to pressing FDA compliance and business related challenges,” said Timothy Petracca, Vice President of VelQuest Corporation. “Our partnership enables customers to rapidly deploy the SmartLab solution directly reducing cost and increasing productivity and quality across their operations.”
This strategic alliance will enable clients to have SmartLab installed and validated by Stelex using it’s proven Common Sense Compliance™ methodology for IT initiatives. Those clients will then further benefit from working together with Stelex and VelQuest, who will implement and validate automated laboratory solutions faster and more cost effectively.
“This strategic alliance will allow Stelex and VelQuest to take a leadership role in laboratory automation solutions for the lifesciences industry by combining the best technologies with proven industry know-how and methodologies” said Daniel R. Matlis, Vice-President at Stelex.
About Stelex
Stelex is a consulting firm providing enterprise-wide compliance solutions to regulated industries in the Pharmaceutical, Medical Device, Diagnostic and Biotechnology sectors for over 20 years. The firm delivers a comprehensive suite of Validation, Technology, Regulatory and Business solutions. Learn more about Stelex at www.stelex.com.
Stelex is a subsidiary of
Vital Signs, Inc. (NASDAQ: VITL).
Vital Signs Inc. provide products and services to the hospital market and FDA regulated industries. Vital Signs is ISO 9001 certified and has CE Mark approval for its products.
About VelQuest
Founded in January, 1999, VelQuest Corporation provides a growing suite of unique products to help transform regulated industries from labor-intensive, paper-based operations to automated, efficient systems with greater confidence in compliance than ever before possible.
The SmartLab solution uses VelQuest’s electronic Process Management & Compliance (ePMC™) Operating System that is an innovative software platform designed to provide the foundation for compliance-based activities in the life science markets. The software embraces the FDA’s “cGMPs for the 21st Century: A Risk Based Approach” initiative, and supports the company’s SmartLab Applications for a fully compliant electronic laboratory including SmartShell™, a 21 CFR Part 11 remediation software, SmartBatch™, an electronic Batch Record System, as well as planned product line extensions.